Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 Mice

Journal of Experimental Medicine

Volumn 179, Issue 1, 1994, Pages 305-310

  Ishida, Hiroshi ^a,c   Muchamuel, Tony ^a   Sakaguchi, Shimon ^a,b   Andrade, Silvia ^a   Menon, Satish ^a   Howard, Maureen ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA; GAMMA INTERFERON; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMAL; ANTIBODIES; AUTOIMMUNITY; FEMALE; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; UP-REGULATION;

EID: 0028081880     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.179.1.305     Document Type: Article

References (30)

1. Bielschowsky, M., B.J. Helyer, and J.B. Howie. 1959. Spontaneous hemolytic anemia in mice of the NZB/B1 strain. Proc. Univ. Otago. Med. Sch. 37:9.
2. Howie, J.B., and B.J. Helyer. 1968. The immunology and pathology of NZB mice. Adv. Immunol. 9:215.
3. Theofilopoulos, A.N., and F.J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
4. Wong, G.H.W., I. Clark-Lewis, J.L. McKinn-Breschkin, A.W. Harris, and J.W. Schrader. 1983. Interferon-y induces enhanced expression of la and H-2 antigens on B lymphoid, macrophage and myeloid cell lines. J. Immunol. 131:788.
5. Ameglio, F., R. Tosi, N. Tanagaki, and A. Doley. 1986. Regulation of HLA class II antigen expression. In HLA Class II Antigens. A Comprehensive Review of Structure and Function. B.G. Solheim, E. Moller, and S. Ferrons, editors. SpringerVerlag New York, Inc., New York. p. 299.
6. Trinchieri, G., and B. Perussia. 1985. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today. 6:131.
7. 1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum. 24:1396.
8. Heremans, H., A. Billan, A. Colombatti, J. Hilders, and P. DeSomer. 1978. Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect. Immun. 21:925.
9. Serfiescu, D., I. Cerutti, E. Efthymiou, A. Kahan, and C. Chanv. 1979. Adverse effects of interferon treatment on the life span of NZB mice. Biomed. Express (Paris). 31:48.
10. Jacob, C.H., P.H. van der Meide, and H.O. McDevitt. 1987. In vivo treatment of (NZB x NZW)Fi lupus-like nephritis with monoclonal antibody to y interferon. J. Exp Med. 166:798.
11. Jacob, C.O., and H.O. McDevitt. 1988. Tumor necrosis factor-α in murine autoimmune ‘lupus’ nephritis. Nature (Lond.). 331: 356.
12. 1 mice. Clin. Immunol. Im-munopathol. 52:421.
13. Jongeneel, C.V., H. Acha-Orbea, and T. Blankenstein. 1990. A polymorphic microsatellite in the tumor necrosis factor a promoter identifies an allele unique to the NZW mouse strain. J. Exp. Med. 171:2141.
14. Jacob, C.O., F. Hwang, G.D. Lewis, and A.M. Stall. 1991. Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cytokine. 3:551.
15. Muller, U., C.V. Jongeneel, and S.A. Nedospasov. 1987. Tumor necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex. Nature (Lond.). 325:265.
16. Dunham, I., C.A. Sargent, J. Trowsdale, and D.R. Campbell. 1987. Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc. Natl. Acad. Sci. USA. 84:7237.
17. Ragoussis, J., K. Bloemer, E.H. Weiss, and A. Zeigler. 1988. Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis. Immunogenetics. 27:66.
18. Howard, M., A. O’Garra, H. Ishida, R. de Waal Malefyt, and J. de Vries. 1992. Biological properties of interleukin 10. J. Clin. Immunol. 12:239.
19. Howard, M., and A. O’Garra. 1992. Biological properties of interleukin 10. Immunol. Today. 13:198.
20. Ishida, H., R. Hastings, J. Kearney, and M. Howard. 1992. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 cells but not conventional B cells. J. Exp. Med. 175:1213.
21. Ishida, H., R. Hastings, L. Thompson-Snipes, and M. Howard. 1993. Modified immunological status of anti-IL-10 treated mice. Cell. Immunol. 148:371.
22. + B cells: the Ly-1 lineage? Annu. Rev. Immunol. 6:197.
23. Mosmann, T.R., J.H. Schumacher, D.F. Fiorentino, J. Leverah, K.W. Moore, and M.W. Bond. 1990. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol. 145: 2938.
24. Abrams, J.S., M.-G. Roncarolo, H. Yssel, U. Andersson, G.J. Gleich, and J.E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
25. Berden, J.H., L. Hang, P.J. McConahey, and F.J. Dixon. 1983. Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J. Immunol. 130:1699.
26. Sakaguchi, S., and N. Sakaguchi. 1990. Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J. Exp. Med. 172:537.
27. Jacob, C.O., Z. Fronek, and G.D. Lewis. 1990. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl. Acad. Sci. USA. 87:1233.
28. Watanabe, Y., and C.O. Jacob. 1991. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell. J. Immunol. 146:899.
29. Bottazo, G.F., R. Pujol-Borrell, T. Hanafusa, and M. Feldmann. 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 2:1115.
30. Gordon, C., and D. Wofsy. 1990. Effects of recombinant murine tumor necrosis factor-a on immune function. J. Immunol. 144:1753.